Status:
UNKNOWN
Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies
Lead Sponsor:
Malaghan Institute of Medical Research
Conditions:
Haematological Malignancy
Leukemia
Eligibility:
All Genders
16-75 years
Brief Summary
The THERMAL study is a pilot study to determine feasibility of using two separate continuous skin temperature monitors during intensive treatment for haematological malignancies. It involves participa...
Detailed Description
Patients with haematological malignancies such as leukaemia, lymphoma and myeloma often require intensive treatments such as chemotherapy, stem cell transplantation (either autologous or allogeneic) o...
Eligibility Criteria
Inclusion
- Age 16-75 years
- Diagnosis of acute leukaemia, lymphoma or myeloma by consultant haematologist or multidisciplinary meeting discussion
- Undergoing treatment with either induction chemotherapy, autologous stem cell transplant, allogeneic stem cell transplant, or chimeric antigen receptor (CAR) T-cell therapy as part of their normal care.
Exclusion
- Medical condition that would result in discomfort from the application of chest or axillary monitoring.
- Allergy to a component of the monitoring devices
- Diminished capacity or any circumstance that would prohibit them from understanding and providing informed consent in accordance with ICH-GCP (International Conference on Harmonisation, Good Clinical Practice) principles.
Key Trial Info
Start Date :
November 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05203809
Start Date
November 18 2021
End Date
June 30 2022
Last Update
January 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Malaghan Institute of Medical Research
Wellington, New Zealand, 6012